The conducted studies showed that patients with AD are characterized by a significantly higher median concentration of fibronectin compared to healthy subjects (652.06 vs. 268.31 μg/mL), but a significantly lower median of MMP-1 (4.62 vs. 18.09 ng/mL). This evidence concerns the gene FN1 and Alzheimer disease.